NYSE:ELANPharmaceuticals
Elanco Animal Health (ELAN) Stock Eyes Margin Momentum As Debt Questions Linger
Elanco Animal Health stock inched up 2.4% to US$26.22 after its second quarter report, a measured move for a business that just put a far stronger profit story on the table than its trailing losses suggest. The headline is margin power. Adjusted EBITDA climbed to US$288 million and adjusted gross margin reached 58.1%, even as revenue came in at US$1.37b. Traders reacted calmly to a set of numbers that point to a company still carrying past unprofitability on its back while current quarter...